Alkami Statements
AL
Data from Alkami`s earning releases including common size income statement and balance sheet.
Common size analysis evaluates financial statements by expressing each line item as a percentage of a base amount for that period.
Key Information:
Report currency:
USD - US dollar
Last reporting period:
30 Sep, 2024
Next reporting period:
29 Dec, 2024
Report frequency:
Quarterly
Earnings release date:
30 Oct, 2024
Expected release date:
—
Alkami Income Statement
B
M
USD (except Earnings per share)
Financial
Revenue
Cost of sales
Gross profit
Research and development
Selling, general and administrative
Total operating expenses
Operating income
Interest expense
Other income
Income before tax
Provision for income taxes
Net income
Diluted earnings per share
Shares outstanding after dilution
85.906
4.6 %
100
35.289
41.1
50.617
3.8 %
58.9
24.133
28.1
36.553
42.5
61.045
-1.3 %
71.1
-10.428
20.2 %
-12.1
0.967
1.1
—
0
-9.461
22 %
-11.01
-0.019
-0.02
-9.442
23.3 %
-11
-0.095
99.435
82.16
7.9 %
100
33.389
40.6
48.771
10.8 %
59.4
23.909
29.1
36.276
44.2
61.843
9.8 %
75.3
-13.072
-6.2 %
-15.9
1.075
1.3
—
0
-12.132
-7.9 %
-14.8
0.185
0.2
-12.317
-7.7 %
-15
-0.126
98.104
76.127
6.7 %
100
32.095
42.2
44.032
10.2 %
57.8
22.82
30
31.958
43.6
56.337
6.3 %
74
-12.305
5.8 %
-16.2
1.121
1.5
—
0
-11.244
13.5 %
-14.8
0.189
0.2
-11.433
10.1 %
-15.02
-0.118
96.945
71.369
5.4 %
100
31.42
44
39.949
9.3 %
56
21.491
30.1
31.155
43.7
53.005
2.1 %
74.3
-13.056
15.2 %
-18.3
0.516
0.7
—
0
-12.992
15.9 %
-18.2
-0.279
-0.4
-12.713
17.9 %
-17.8
-0.133
95.891
67.7
3 %
100
31.15
46
36.55
3 %
54
21.76
32.1
29.82
44
51.94
-2.6 %
76.7
-15.39
13.7 %
-22.7
0.35
0.5
—
0
-15.44
12.6 %
-22.8
0.04
0.06
-15.48
12.8 %
-22.9
-0.16
94.68
65.76
9.6 %
100
30.29
46.1
35.47
10.4 %
53.9
20.87
31.7
32.09
48.8
53.32
9.1 %
81.1
-17.84
-6.4 %
-27.1
0.2
0.3
—
0
-17.67
-5.4 %
-26.9
0.09
0.1
-17.76
-4.7 %
-27.007
-0.19
93.33
60
8 %
100
27.86
46.4
32.14
12.1 %
53.6
20.55
34.3
27.99
46.6
48.89
4.4 %
81.5
-16.76
7.7 %
-27.9
0.18
0.3
—
0
-16.77
-207.7 %
-27.9
0.2
0.3
-16.96
-245.4 %
-28.3
-0.18
92.4
55.54
4 %
100
26.87
48.4
28.67
4 %
51.6
20.36
36.7
26.12
47
46.83
0.4 %
84.3
-18.16
4.8 %
-32.7
0.03
0.05
—
0
-5.45
73 %
-9.8
-0.54
-1
-4.91
75.5 %
-8.8
-0.05
91.72
53.41
5.7 %
100
25.84
48.4
27.57
1.1 %
51.6
18.22
34.1
28.06
52.5
46.65
1.7 %
87.3
-19.08
-2.6 %
-35.7
-0.39
-0.7
—
0
-20.21
-0.6 %
-37.8
-0.16
-0.3
-20.05
0.9 %
-37.5
-0.22
91.18
50.53
12.8 %
100
23.26
46
27.27
9.9 %
54
16.6
32.9
28.94
57.3
45.86
21.3 %
90.8
-18.59
-42.9 %
-36.8
-0.62
-1.2
—
0
-20.08
-50.8 %
-39.7
0.16
0.3
-20.23
-50.9 %
-40.04
-0.22
90.71
44.79
5.5 %
100
19.98
44.6
24.81
7.2 %
55.4
14.16
31.6
23.66
52.8
37.82
4.6 %
84.4
-13.01
0.1 %
-29.05
-0.31
-0.7
—
0
-13.32
-1.1 %
-29.7
0.09
0.2
-13.41
-0.4 %
-29.9
-0.15
90.21
42.44
6.7 %
100
19.29
45.5
23.15
3.5 %
54.5
12.9
30.4
23.27
54.8
36.17
7.9 %
85.2
-13.02
-16.9 %
-30.7
-0.16
-0.4
—
0
-13.18
-17.5 %
-31.06
0.17
0.4
-13.35
-19 %
-31.5
-0.15
89.95
39.76
8.3 %
100
17.39
43.7
22.37
9 %
56.3
12.88
32.4
20.64
51.9
33.51
10.5 %
84.3
-11.14
-13.6 %
-28.02
-0.08
-0.2
—
0
-11.22
1.4 %
-28.2
—
0
-11.22
1.4 %
-28.2
-0.13
88.15
36.7
10.3 %
100
16.18
44.1
20.52
15.5 %
55.9
12.81
34.9
17.52
47.7
30.33
13.6 %
82.6
-9.81
-9.7 %
-26.7
-1.56
-4.3
—
0
-11.38
-4.6 %
-31.008
—
0
-11.38
-2 %
-31.008
-0.13
87.19
33.26
14.9 %
100
15.5
46.6
17.77
17.1 %
53.4
10.91
32.8
15.79
47.5
26.7
22.8 %
80.3
-8.94
-35.7 %
-26.9
-1.94
-5.8
—
0
-10.88
49 %
-32.7
—
0
-11.16
56.8 %
-33.6
-0.13
85.94
28.94
8.5 %
100
13.78
47.6
15.17
13 %
52.4
9.9
34.2
11.86
41
21.75
5.9 %
75.2
-6.59
7.3 %
-22.8
-14.76
-51.002
—
0
-21.35
-193.7 %
-73.8
—
0
-25.81
-242.3 %
-89.2
-0.31
83.14
26.67
—
100
13.24
49.6
13.43
—
50.4
9.78
36.7
10.76
40.3
20.54
—
77
-7.11
—
-26.7
-0.16
-0.6
—
0
-7.27
—
-27.3
—
0
-7.54
—
-28.3
-0.09
83.14